These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23484069)

  • 21. Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.
    Yakar S; Isaksson O
    Growth Horm IGF Res; 2016 Jun; 28():26-42. PubMed ID: 26432542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
    Green J; Goldberg R; Maor G
    Kidney Int; 2003 Feb; 63(2):487-500. PubMed ID: 12631114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.
    Zhou W; Rowitz BM; Dailey MJ
    Exp Biol Med (Maywood); 2018 Jul; 243(11):911-916. PubMed ID: 29950119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways.
    Sakata T; Wang Y; Halloran BP; Elalieh HZ; Cao J; Bikle DD
    J Bone Miner Res; 2004 Mar; 19(3):436-46. PubMed ID: 15040832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in understanding the anti-diabetic actions of dietary flavonoids.
    Babu PV; Liu D; Gilbert ER
    J Nutr Biochem; 2013 Nov; 24(11):1777-89. PubMed ID: 24029069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B; Cheng HL; Margolis B; Feldman EL
    J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase Calpha-mediated negative regulation of Akt.
    Rose A; Froment P; Perrot V; Quon MJ; LeRoith D; Dupont J
    J Biol Chem; 2004 Dec; 279(50):52500-16. PubMed ID: 15448167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
    Jackson JG; White MF; Yee D
    J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat.
    Ahmad T; Ugarph-Morawski A; Lewitt MS; Li J; Sääf M; Brismar K
    Growth Horm IGF Res; 2008 Oct; 18(5):404-411. PubMed ID: 18381245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats.
    Zhao YF; Zeng DL; Xia LG; Zhang SM; Xu LY; Jiang XQ; Zhang FQ
    Int J Mol Med; 2013 Mar; 31(3):614-20. PubMed ID: 23292283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF-I/PI3K/Akt and IGF-I/MAPK/ERK pathways in vivo in skeletal muscle are regulated by nutrition and contribute to somatic growth in the fine flounder.
    Fuentes EN; Björnsson BT; Valdés JA; Einarsdottir IE; Lorca B; Alvarez M; Molina A
    Am J Physiol Regul Integr Comp Physiol; 2011 Jun; 300(6):R1532-42. PubMed ID: 21389330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
    Scalia P; Heart E; Comai L; Vigneri R; Sung CK
    J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
    Hie M; Iitsuka N; Otsuka T; Tsukamoto I
    Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
    Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin and insulin-like growth factor-1 action on human skeletal muscle: preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects.
    Ciaraldi TP; Carter L; Rehman N; Mohideen P; Mudaliar S; Henry RR
    Metabolism; 2002 Sep; 51(9):1171-9. PubMed ID: 12200763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms Underlying the Synergistic Action of Insulin and Growth Hormone on IGF-I and -II Expression in Grass Carp Hepatocytes.
    Jiang Q; Bai J; He M; Yuen KWY; Wong AOL
    Front Endocrinol (Lausanne); 2018; 9():336. PubMed ID: 29977227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.